We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesTenon Medical Inc

Tenon Medical Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
1.82 USD 0.07 ( 4.30%)
Last update at 2026-11-12T15:53:00Z
VOLUME
54608
Market Cap
2.69M

Momentum Score

…

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.75
Low
1.82
High
52 Week Price Range
0.70
Low
13.70
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Tenon Medical Inc (NASDAQ: TNON) is a publicly listed medical device company; public disclosures about its products and operations are limited. Its long-term growth could be driven by regulatory approvals, successful product commercialization, partnerships, and broader healthcare demand for innovative surgical or therapeutic devices, which may benefit from an aging population and higher procedure volumes.
Material risks include dependence on regulatory approval and commercialization execution, potential need for additional financing, manufacturing and reimbursement challenges, and substantial competition in the medical device sector.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.75
Dividend Yield
-
Revenue TTM
2.93M
Revenue Per Share
1.61
Gross Profit TTM
-0.64M
Debt / Equity
2.39
ROE
-443.27%
Net Debt
-0.57M
ROCE
-584.24%
Diluted EPS TTM
-80.27

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -18.92M -7.08M -0.71M -
Minority interest 0.00M 0.03M 0.12M -
Net income -19.11M -7.67M -0.75M -
Selling general administrative 7.42M 2.71M 0.31M -
Selling and marketing expenses 7.83M 2.14M 0.03M -
Gross profit -0.64M 0.11M 0.03M -
Reconciled depreciation 0.29M 0.11M 0.00M -
Ebit -18.73M -6.46M -0.54M -0.53M
Ebitda -18.45M -6.35M -0.54M -
Depreciation and amortization 0.27M 0.11M -0.00M -
Operating income -18.73M -6.46M -0.54M -
Other operating expenses 19.42M 6.62M 0.58M -
Interest expense 0.35M 0.62M 0.17M 0.00M
Net interest income -0.35M -0.62M -0.17M -
Income tax expense 0.19M 0.59M 0.05M -
Total revenue 0.69M 0.16M 0.04M -
Total operating expenses 18.08M 6.57M 0.56M -
Cost of revenue 1.33M 0.05M 0.02M -
Total other income expense net -0.19M -0.62M -0.17M -
Net income from continuing ops -18.92M -7.08M -0.71M -
Net income applicable to common shares -18.92M -7.05M -0.59M -0.51M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 6.34M 11.09M 9.27M 0.39M -
Other current assets 0.38M 0.13M 0.09M - -
Total liab 5.57M 4.84M 29.82M 3.10M -
Total stockholder equity 0.78M 6.25M -20.55M -4.42M -
Deferred long term liab - 0.03M 0.37M 0.09M -
Other current liab 1.28M 1.75M 1.09M 0.66M -
Common stock 0.00M 0.01M 0.00M 0.00M 0.00M
Capital stock - 0.01M 0.00M 0.00M -
Retained earnings -55.07M -39.49M -20.58M -4.49M -3.90M
Other liab - 1.62M - - -
Other assets - 0.08M 0.42M 0.09M -
Cash 2.43M 2.13M 2.92M 0.25M -
Total current liabilities 3.14M 2.53M 15.27M 1.49M 1.69M
Net debt -0.57M -1.22M 11.70M 0.33M -
Short term debt 1.43M 0.23M 13.71M 0.24M -
Short long term debt - - 13.51M 0.24M -
Short long term debt total 1.86M 0.91M 14.62M 0.57M -
Other stockholder equity 55.89M 34.74M 0.11M 0.13M -0.03M
Property plant equipment - 1.67M 1.18M - -
Total current assets 3.89M 9.35M 7.67M 0.30M 0.27M
Net tangible assets - 6.25M -20.55M -4.42M -3.88M
Short term investments - 6.44M 4.40M 0.00M -
Net receivables 0.53M 0.23M 0.08M 0.01M 0.05M
Long term debt - - - 0.33M -
Inventory 0.55M 0.41M 0.19M 0.04M 0.06M
Accounts payable 0.43M 0.55M 0.48M 0.59M 0.45M
Accumulated other comprehensive income -0.05M -0.10M -0.09M -0.06M -
Non currrent assets other 0.85M 0.08M 0.42M 0.09M -
Non current assets total 2.46M 1.74M 1.60M 0.09M -
Capital lease obligations - 0.91M 1.11M 0.00M -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -2.88M -4.40M -4.40M -4.40M
Change to liabilities 0.07M 0.44M 0.14M 0.27M
Total cashflows from investing activities -2.88M -4.50M -4.50M -4.50M
Net borrowings - 11.83M 0.31M 0.32M
Total cash from financing activities 14.11M 11.47M 0.25M 0.32M
Change to operating activities 2.03M 0.21M 0.15M 0.11M
Net income -18.92M -7.08M -0.71M -0.51M
Change in cash -0.79M 2.67M 0.09M 0.09M
Begin period cash flow 2.92M 0.25M 0.15M -
End period cash flow 2.13M 2.92M 0.25M 0.15M
Total cash from operating activities -12.03M -4.29M -0.17M -0.24M
Issuance of capital stock 14.14M - - -
Depreciation 0.29M 0.11M 0.11M 0.11M
Change to inventory -0.23M -0.15M 0.02M -0.06M
Change to account receivables -0.15M -0.06M 0.04M -0.05M
Other cashflows from financing activities -0.03M 11.71M 0.25M -0.05M
Change to netincome 4.88M 2.19M 0.06M 0.01M
Capital expenditures 0.85M 0.10M 0.10M 0.10M
Change in working capital 1.72M 0.45M 0.35M -
Stock based compensation 2.90M 0.38M 0.02M -
Other non cash items 1.98M 1.85M 0.17M -
Free cash flow -12.87M -4.39M -0.17M -

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
TNON
Tenon Medical Inc		 0.07
4.30%		 1.82 - - 1.02 3.84 0.82 -0.16
ABT
Abbott Laboratories		 -0.71
0.65%		 108.58 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 0.28
0.28%		 101.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -2.16
0.68%		 316.63 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -
-%		 47.31 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Tenon Medical Inc

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

104 Cooper Court, Los Gatos, CA, United States, 95032

408 649 5760

https://www.tenonmed.com

21

Name Title Year Born
Mr. Steven M. Foster CEO & Chairman 1967
Mr. Richard Ginn Founder, CTO & Director 1966
Mr. Steven M. Van Dick Exec. VP of Fin. & Admin. and CFO 1955
Mr. Richard M. Ferrari Exec. Chairman 1954
Mr. Richard M. Ferrari Founder & Executive Chairman 1954
Mr. Steven M. Foster CEO, President & Director 1968
Mr. Steven M. Van Dick Executive VP of Finance & Administration and CFO 1955

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…